193 related articles for article (PubMed ID: 32171811)
21. Cytokine profiling of ascites at primary surgery identifies an interaction of tumor necrosis factor-α and interleukin-6 in predicting reduced progression-free survival in epithelial ovarian cancer.
Kolomeyevskaya N; Eng KH; Khan AN; Grzankowski KS; Singel KL; Moysich K; Segal BH
Gynecol Oncol; 2015 Aug; 138(2):352-7. PubMed ID: 26001328
[TBL] [Abstract][Full Text] [Related]
22. Role of tumor necrosis factor-α in the mortality of hospitalized patients with severe and critical COVID-19 pneumonia.
Jia F; Wang G; Xu J; Long J; Deng F; Jiang W
Aging (Albany NY); 2021 Nov; 13(21):23895-23912. PubMed ID: 34725309
[TBL] [Abstract][Full Text] [Related]
23. Research on the relationship between serum levels of inflammatory cytokines and non-small cell lung cancer.
Song XY; Zhou SJ; Xiao N; Li YS; Zhen DZ; Su CY; Liu ZD
Asian Pac J Cancer Prev; 2013; 14(8):4765-8. PubMed ID: 24083740
[TBL] [Abstract][Full Text] [Related]
24. Immune cytokine response in combat casualties: blast or explosive trauma with or without secondary sepsis.
Surbatovic M; Filipovic N; Radakovic S; Stankovic N; Slavkovic Z
Mil Med; 2007 Feb; 172(2):190-5. PubMed ID: 17357775
[TBL] [Abstract][Full Text] [Related]
25. Correlations between skin lesions induced by anti-tumor necrosis factor-α and selected cytokines in Crohn's disease patients.
Włodarczyk M; Sobolewska A; Wójcik B; Loga K; Fichna J; Wiśniewska-Jarosińska M
World J Gastroenterol; 2014 Jun; 20(22):7019-26. PubMed ID: 24944497
[TBL] [Abstract][Full Text] [Related]
26. Association of IL-6, IL-10, and TNF-α gene polymorphism with malnutrition inflammation syndrome and survival among end stage renal disease patients.
Sharma R; Agrawal S; Saxena A; Sharma RK
J Interferon Cytokine Res; 2013 Jul; 33(7):384-91. PubMed ID: 23777202
[TBL] [Abstract][Full Text] [Related]
27. Prognostic role of serum cytokines in patients with nasopharyngeal carcinoma.
Lu K; Feng X; Deng Q; Sheng L; Liu P; Xu S; Su D
Onkologie; 2012; 35(9):494-8. PubMed ID: 23007146
[TBL] [Abstract][Full Text] [Related]
28. Cytokine gene polymorphisms and serum cytokine levels in patients with idiopathic pulmonary fibrosis.
Alhamad EH; Cal JG; Shakoor Z; Almogren A; AlBoukai AA
BMC Med Genet; 2013 Jul; 14():66. PubMed ID: 23815594
[TBL] [Abstract][Full Text] [Related]
29. High serum levels of soluble interleukin-2 receptor (sIL2-R), interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF) are associated with adverse clinical features and predict poor outcome in diffuse large B-cell lymphoma.
Dlouhy I; Filella X; Rovira J; Magnano L; Rivas-Delgado A; Baumann T; Martínez-Trillos A; Balagué O; Martínez A; González-Farre B; Karube K; Gine E; Delgado J; Campo E; López-Guillermo A
Leuk Res; 2017 Aug; 59():20-25. PubMed ID: 28544905
[TBL] [Abstract][Full Text] [Related]
30. Circulating blood levels of IL-6, IFN-γ, and IL-10 as potential diagnostic biomarkers in gastric cancer: a controlled study.
Sánchez-Zauco N; Torres J; Gómez A; Camorlinga-Ponce M; Muñoz-Pérez L; Herrera-Goepfert R; Medrano-Guzmán R; Giono-Cerezo S; Maldonado-Bernal C
BMC Cancer; 2017 May; 17(1):384. PubMed ID: 28558708
[TBL] [Abstract][Full Text] [Related]
31. Serum levels of interleukin-6 and tumor necrosis factor-alpha in exacerbation and remission phase of schizophrenia.
Dunjic-Kostic B; Jasovic-Gasic M; Ivkovic M; Radonjic NV; Pantovic M; Damjanovic A; Poznanovic ST; Jovanovic A; Nikolic T; Petronijevic ND
Psychiatr Danub; 2013 Mar; 25(1):55-61. PubMed ID: 23470607
[TBL] [Abstract][Full Text] [Related]
32. The impact of disease activity and tumour necrosis factor-α inhibitor therapy on cytokine levels in juvenile idiopathic arthritis.
Walters HM; Pan N; Lehman TJ; Adams A; Kalliolias GD; Zhu YS; Santiago F; Nguyen J; Sitaras L; Cunningham-Rundles S; Walsh TJ; Toussi SS
Clin Exp Immunol; 2016 Jun; 184(3):308-17. PubMed ID: 26934060
[TBL] [Abstract][Full Text] [Related]
33. Association of Parkinson's disease-related pain with plasma interleukin-1, interleukin-6, interleukin-10, and tumour necrosis factor-α.
Li D; Song X; Huang H; Huang H; Ye Z
Neurosci Lett; 2018 Sep; 683():181-184. PubMed ID: 30063943
[TBL] [Abstract][Full Text] [Related]
34. Serum interleukin-2, interleukin-6, tumour necrosis factor-alpha and nitric oxide levels in patients with Behcet's disease.
Akdeniz N; Esrefoglu M; Keleş MS; Karakuzu A; Atasoy M
Ann Acad Med Singap; 2004 Sep; 33(5):596-9. PubMed ID: 15531955
[TBL] [Abstract][Full Text] [Related]
35. Contributing role of TNF, IL-10, sTNFR1 and TNF gene polymorphisms in disease severity of leptospirosis.
Nisansala T; Weerasekera M; Ranasinghe N; Marasinghe C; Gamage C; Fernando N; Gunasekara C
Med Microbiol Immunol; 2021 Aug; 210(4):211-219. PubMed ID: 34164720
[TBL] [Abstract][Full Text] [Related]
36. Interleukin-6 but not tumour necrosis factor-alpha predicts survival in patients with advanced cancer.
Suh SY; Choi YS; Yeom CH; Kwak SM; Yoon HM; Kim DG; Koh SJ; Park J; Lee MA; Lee YJ; Seo AR; Ahn HY; Yim E
Support Care Cancer; 2013 Nov; 21(11):3071-7. PubMed ID: 23828393
[TBL] [Abstract][Full Text] [Related]
37. Elevated plasma levels of tumor necrosis factor (TNF)-alpha, soluble TNF receptors, interleukin (IL)-6, and IL-10 in patients with hemorrhagic fever with renal syndrome.
Linderholm M; Ahlm C; Settergren B; Waage A; Tärnvik A
J Infect Dis; 1996 Jan; 173(1):38-43. PubMed ID: 8537680
[TBL] [Abstract][Full Text] [Related]
38. Effect of intraoperative glucose fluctuation and postoperative IL-6, TNF-α, CRP levels on the short-term prognosis of patients with intracranial supratentorial neoplasms.
Liu TC; Liu QR; Huang Y
Asian Pac J Cancer Prev; 2014; 15(24):10879-82. PubMed ID: 25605194
[TBL] [Abstract][Full Text] [Related]
39. Inflammatory Markers and Outcomes in Kidney Transplant Recipients.
Molnar MZ; Nagy K; Remport A; Tapolyai MB; Fülöp T; Kamal F; Kovesdy CP; Mucsi I; Mathe Z
Transplantation; 2017 Sep; 101(9):2152-2164. PubMed ID: 27798514
[TBL] [Abstract][Full Text] [Related]
40. Relationships between increased circulating YKL-40, IL-6 and TNF-α levels and phenotypes and disease activity of primary Sjögren's syndrome.
Chen C; Liang Y; Zhang Z; Zhang Z; Yang Z
Int Immunopharmacol; 2020 Nov; 88():106878. PubMed ID: 32791244
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
